Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons--2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America: (548462006-001)
Abstract
In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelines were updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended for clinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed or infected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure to opportunistic pathogens, preventing first episodes of disease by chemoprophylaxis or vaccination (primary prophylaxis), and preventing disease recurrence (secondary prophylaxis). Major changes since the last edition of the guidelines include 1) updated recommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4+ T lymphocyte counts have increased in response to antiretroviral therapy; 2) emphasis on screening all HIV-infected persons for infection with hepatitis C virus; 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regarding drug interactions, chiefly related to rifamycins and antiretroviral drugs; and 5) revised recommendations for immunizing HIV-infected adults and adolescents and HIV-exposed or infected children.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The first-line treatment and prophylaxis regimen for Pneumocystis pneumonia (PCP) is trimethoprim-sulfamethoxazole (TMP-SMX).
“The first-line treatment and prophylaxis regimen for PCP is trimethoprim-sulfamethoxazole (TMP-SMX) (4).”
From Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance (2004) · cites this paper as [4]
Cited by
Sorted by citations
Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance
Huang, L., Crothers, K., Atzori, C., Benfield, T., Miller, R., Rabodonirina, M., & Helweg-Larsen, J. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1010.030994 · Cited by 131 · see citing works
Nahimana, A., Rabodonirina, M., Zanetti, G., Meneau, I., Francioli, P., Bille, J., & Hauser, P. M. (2003) · The Journal of Infectious Diseases · doi:10.1086/378239 · Cited by 71 · see citing works
- Authors
- Kaplan, J. E., Masur, H., & Holmes, K. K.
- Affiliations
- National Center for Infectious Diseases (US)
- Venue
- PsycEXTRA Dataset
- Published
- 2002
- Volume
- 51
- Issue
- RR-8
- Pages
- 1-52
- OpenAlex
- W2286580524
- Cited by
- 292
- References
- 0
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 3 · 2015: 8 · 2014: 11 · 2013: 12 · 2012: 12
- Type
- dataset
- Language
- en
- Open access
- closed
- Locations
- PsycEXTRA Dataset (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
- Keywords
- opportunistic infections, HIV infection, chemoprophylaxis, primary prophylaxis, secondary prophylaxis, CD4 count, antiretroviral therapy, HCV screening, human herpesvirus 8, rifamycin, drug interactions, vaccination, HIV-exposed children, HIV-exposed infants, HIV in pregnancy, HIV-infected adolescents
- MeSH terms
- Adult, Animals, Animals, Domestic, Bacterial Infections, Bartonella Infections, Candidiasis, Chickenpox, Child, Cryptococcosis, Cryptosporidiosis, Cytomegalovirus Infections, Environmental Exposure, Food, Gastrointestinal Diseases, Hepatitis C, Herpes Simplex, Herpes Zoster, Humans, Pneumonia, Pneumocystis, Respiratory Tract Infections, Sarcoma, Kaposi, Sexually Transmitted Diseases, Travel, Tuberculosis, Mycobacterium avium-intracellulare Infection, Substance Abuse, Intravenous, Occupational Exposure, Toxoplasmosis, Cerebral, AIDS-Related Opportunistic Infections, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review